Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Chongqing Zhifei Biological Products Co., Ltd.
—
Chongqing Zhifei Biological Products Co., Ltd. is led by CEO Lingfeng Jiang, employs 6,292 people, headquartered in Chongqing, CN, publicly traded since 2010.
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) stock trades at $12.43 with a market capitalization of $31.60B. The stock is valued at a negative price-to-earnings (P/E) ratio of -31.43, reflecting a net loss over the last twelve months, price-to-book of 2.10, price-to-sales of 3.92. Over the past 52 weeks the stock has ranged between $11.07 and $22.18, and currently trades 44.0% below its 52-week high.
On profitability, Chongqing Zhifei Biological Products Co., Ltd. generates a return on equity (ROE) of -65.69% (negative, reflecting a net loss), an operating margin of -26.69%, a net profit margin of -185.32%.
The balance sheet shows a debt-to-equity ratio of 0.67, a current ratio of 2.98.
300122.SZ has an average daily trading volume of 35,520,945 shares, a beta of 0.45 (historically less volatile than the overall market), 2.39B shares outstanding.
Official website: www.zhifeishengwu.com
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) — frequently asked questions
What is Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) stock price today?
Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ) is currently trading at $12.43, down 1.11% today.
What is 300122.SZ P/E ratio?
Chongqing Zhifei Biological Products Co., Ltd.'s P/E ratio is -31.43. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300122.SZ return on equity (ROE)?
Chongqing Zhifei Biological Products Co., Ltd.'s return on equity (ROE) is -65.69%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Chongqing Zhifei Biological Products Co., Ltd.'s market cap?
Chongqing Zhifei Biological Products Co., Ltd. has a market capitalization of $31.60B.
Does 300122.SZ pay a dividend?
Chongqing Zhifei Biological Products Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 300122.SZ carry?
Chongqing Zhifei Biological Products Co., Ltd. has a debt-to-equity ratio of 0.67. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300122.SZ's profit margin?
Chongqing Zhifei Biological Products Co., Ltd. reports a net profit margin of -185.32% — the share of revenue left after every cost, including tax and interest.
What sector is 300122.SZ in?
Chongqing Zhifei Biological Products Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300122.SZ listed on?
Chongqing Zhifei Biological Products Co., Ltd. trades on SHZ under the ticker 300122.SZ.
What is 300122.SZ's 52-week range?
Over the last year Chongqing Zhifei Biological Products Co., Ltd. has traded between $11.07 and $22.18.
Related — Stocks
Popular Stocks
Screens 300122.SZ currently matches
On the figures above, Chongqing Zhifei Biological Products Co., Ltd. passes the filters for 5 of our ready-made screens, among them Large Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.